Statistics
Publications
11
Citations
1.1K
H-Index
11
Active since
2002
Barbara Zemann is an author at Novartis (Austria) specializing in life sciences, immunology, and cell signaling.
Publications per year
2002–2023
11
11
David J. Murphy, Antonia Ricci, Zanda Auce et al. · EFSA Journal · 2017 · 314 citations · Full text
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
Barbara Zemann, Bernd Kinzel, Mathias Müller et al. · Blood · 2005 · 262 citations · Full text
PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text
1–5 of 11